Alistair Mathie, Ph.D. - Publications

Affiliations: 
University of Leicester, Leicester, England, United Kingdom 

87 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Walsh Y, Leach M, Veale EL, Mathie A. Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092. Biochemistry and Biophysics Reports. 26: 101021. PMID 34041373 DOI: 10.1016/j.bbrep.2021.101021  0.302
2020 Mathie A, Veale EL, Cunningham KP, Holden RG, Wright PD. Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond. Annual Review of Pharmacology and Toxicology. PMID 32679007 DOI: 10.1146/Annurev-Pharmtox-030920-111536  0.395
2019 Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets. British Journal of Pharmacology. 176: S1-S20. PMID 31710719 DOI: 10.1111/Bph.14747  0.321
2019 Alexander SP, Cidlowski JA, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors. British Journal of Pharmacology. 176: S229-S246. PMID 31710718 DOI: 10.1111/Bph.14750  0.303
2019 Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology. 176: S21-S141. PMID 31710717 DOI: 10.1111/Bph.14748  0.325
2019 Alexander SP, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors. British Journal of Pharmacology. 176: S247-S296. PMID 31710716 DOI: 10.1111/Bph.14751  0.326
2019 Alexander SP, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology. 176: S142-S228. PMID 31710715 DOI: 10.1111/Bph.14749  0.344
2019 Alexander SP, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology. 176: S297-S396. PMID 31710714 DOI: 10.1111/Bph.14752  0.324
2019 Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters. British Journal of Pharmacology. 176: S397-S493. PMID 31710713 DOI: 10.1111/Bph.14753  0.323
2019 Wright PD, McCoull D, Walsh Y, Large JM, Hadrys BW, Gaurilcikaite E, Byrom L, Veale EL, Jerman J, Mathie A. Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2. Biochemical and Biophysical Research Communications. PMID 31564414 DOI: 10.1016/J.Bbrc.2019.09.093  0.363
2019 Al-Moubarak E, Veale EL, Mathie A. Pharmacologically reversible, loss of function mutations in the TM2 and TM4 inner pore helices of TREK-1 K2P channels. Scientific Reports. 9: 12394. PMID 31455781 DOI: 10.1038/S41598-019-48855-1  0.401
2019 Cunningham KP, MacIntyre DE, Mathie A, Veale EL. Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channels. Acta Physiologica (Oxford, England). e13361. PMID 31423744 DOI: 10.1111/Apha.13361  0.304
2018 Cunningham KP, Holden RG, Escribano-Subias P, Cogolludo A, Veale EL, Mathie A. Characterisation and regulation of wild type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension. The Journal of Physiology. PMID 30365877 DOI: 10.1113/Jp277275  0.376
2018 Fernández-Fernández D, Cadaveira-Mosquera A, Rueda-Ruzafa L, Herrera-Pérez S, Veale EL, Reboreda A, Mathie A, Lamas JA. Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons. Plos One. 13: e0199282. PMID 29928032 DOI: 10.1371/Journal.Pone.0199282  0.414
2017 Loucif AJC, Saintot PP, Liu J, Antonio BM, Zellmer SG, Yoger K, Veale EL, Wilbrey A, Omoto K, Cao L, Gutteridge A, Castle NA, Stevens EB, Mathie A. GI-530159, a novel, selective, mechano-sensitive K2P channel opener, reduces rat dorsal root ganglion (DRG) neuron excitability. British Journal of Pharmacology. PMID 29150838 DOI: 10.1111/Bph.14098  0.381
2017 Olschewski A, Veale EL, Nagy BM, Nagaraj C, Kwapiszewska G, Antigny F, Lambert M, Humbert M, Czirják G, Enyedi P, Mathie A. TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications. The European Respiratory Journal. 50. PMID 29122916 DOI: 10.1183/13993003.00754-2017  0.385
2017 Wright PD, Veale EL, McCoull D, Tickle DC, Large JM, Ococks E, Gothard G, Kettleborough C, Mathie A, Jerman J. Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3. Biochemical and Biophysical Research Communications. PMID 28882594 DOI: 10.1016/J.Bbrc.2017.09.002  0.367
2016 Veale EL, Mathie A. Aristolochic acid, a plant extract used in the treatment of pain and linked to Balkan Endemic Nephropathy, is a regulator of K2P channels. British Journal of Pharmacology. PMID 26914156 DOI: 10.1111/Bph.13465  0.377
2015 Mathie A, Veale EL. Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain. PflüGers Archiv : European Journal of Physiology. 467: 931-43. PMID 25420526 DOI: 10.1007/S00424-014-1655-3  0.39
2014 Veale EL, Al-Moubarak E, Bajaria N, Omoto K, Cao L, Tucker SJ, Stevens EB, Mathie A. Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels. Molecular Pharmacology. 85: 671-81. PMID 24509840 DOI: 10.1124/Mol.113.091199  0.405
2014 Veale EL, Hassan M, Walsh Y, Al-Moubarak E, Mathie A. Recovery of current through mutated TASK3 potassium channels underlying birk barel syndrome Molecular Pharmacology. 85: 397-407. PMID 24342771 DOI: 10.1124/Mol.113.090530  0.406
2014 El Hachmane MF, Rees KA, Veale EL, Sumbayev VV, Mathie A. Enhancement of TWIK-related acid-sensitive potassium channel 3 (TASK3) two-pore domain potassium channel activity by tumor necrosis factor α Journal of Biological Chemistry. 289: 1388-1401. PMID 24307172 DOI: 10.1074/Jbc.M113.500033  0.429
2014 Al-Moubarak E, Mathie A. Enhancement of Current through Trek1 Two Pore Domain Channels by Flufenamic Acid Biophysical Journal. 106. DOI: 10.1016/J.Bpj.2013.11.4121  0.348
2011 Alexander SP, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 5th edition. British Journal of Pharmacology. 164: S1-324. PMID 22040146 DOI: 10.1111/J.1476-5381.2011.01649_1.X  0.39
2011 Alexander S, Mathie A, Peters J. ION CHANNELS: Ion Channels British Journal of Pharmacology. 164. DOI: 10.1111/J.1476-5381.2011.01649_5.X  0.347
2011 Alexander S, Mathie A, Peters J. Ligand‐Gated Ion Channels British Journal of Pharmacology. 164. DOI: 10.1111/J.1476-5381.2011.01649_4.X  0.347
2010 Mathie A, Rees KA, El Hachmane MF, Veale EL. Trafficking of neuronal two pore domain potassium channels. Current Neuropharmacology. 8: 276-86. PMID 21358977 DOI: 10.2174/157015910792246146  0.406
2010 Mathie A. Ion channels as novel therapeutic targets in the treatment of pain Journal of Pharmacy and Pharmacology. 62: 1089-1095. PMID 20796186 DOI: 10.1111/J.2042-7158.2010.01131.X  0.311
2010 Veale EL, Rees KA, Mathie A, Trapp S. Dominant negative effects of a non-conducting TREK1 splice variant expressed in brain Journal of Biological Chemistry. 285: 29295-29304. PMID 20605797 DOI: 10.1074/Jbc.M110.108423  0.349
2010 Mathie A, Al-Moubarak E, Veale EL. Gating of two pore domain potassium channels Journal of Physiology. 588: 3149-3156. PMID 20566661 DOI: 10.1113/Jphysiol.2010.192344  0.424
2008 Clarke CE, Veale EL, Wyse K, Vandenberg JI, Mathie A. The M1P1 loop of TASK3 K2P channels apposes the selectivity filter and influences channel function Journal of Biological Chemistry. 283: 16985-16992. PMID 18417474 DOI: 10.1074/Jbc.M801368200  0.374
2008 Alexander SP, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 3rd edition. British Journal of Pharmacology. 153: S1-209. PMID 18347570 DOI: 10.1038/Sj.Bjp.0707746  0.377
2008 Alexander SPH, Mathie A, Peters JA. A Key to the Tables British Journal of Pharmacology. 153: S3-S3. DOI: 10.1038/Sj.Bjp.0707201  0.353
2007 Veale EL, Buswell R, Clarke CE, Mathie A. Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide British Journal of Pharmacology. 152: 778-786. PMID 17828294 DOI: 10.1038/Sj.Bjp.0707436  0.399
2007 Brickley SG, Aller MI, Sandu C, Veale EL, Alder FG, Sambi H, Mathie A, Wisden W. TASK-3 two-pore domain potassium channels enable sustained high-frequency firing in cerebellar granule neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 9329-40. PMID 17728447 DOI: 10.1523/Jneurosci.1427-07.2007  0.426
2007 Mathie A, Veale EL. Therapeutic potential of neuronal two-pore domain potassium-channel modulators Current Opinion in Investigational Drugs. 8: 555-562. PMID 17659475  0.314
2007 Veale EL, Kennard LE, Sutton GL, MacKenzie G, Sandu C, Mathie A. G(alpha)q-mediated regulation of TASK3 two-pore domain potassium channels: the role of protein kinase C. Molecular Pharmacology. 71: 1666-75. PMID 17374744 DOI: 10.1124/Mol.106.033241  0.434
2007 Alexander SP, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision). British Journal of Pharmacology. 150: S1-168. PMID 17279063 DOI: 10.1038/Sj.Bjp.0707199  0.387
2007 Mathie A. Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors Journal of Physiology. 578: 377-385. PMID 17068099 DOI: 10.1113/Jphysiol.2006.121582  0.412
2007 Alexander SPH, Mathie A, Peters JA. Cell‐Surface Transmitter Transporters British Journal of Pharmacology. 150. DOI: 10.1038/Sj.Bjp.0707207  0.343
2007 Alexander SPH, Mathie A, Peters JA. Transmitter‐Gated Channels British Journal of Pharmacology. 150. DOI: 10.1038/Sj.Bjp.0707203  0.388
2006 Alexander SP, Mathie A, Peters JA. Guide to receptors and channels, 2nd edition. British Journal of Pharmacology. 147: S1-168. PMID 16550176 DOI: 10.1038/Sj.Bjp.0706651  0.396
2006 Mathie A, Sutton GL, Clarke CE, Veale EL. Zinc and copper: Pharmacological probes and endogenous modulators of neuronal excitability Pharmacology and Therapeutics. 111: 567-583. PMID 16410023 DOI: 10.1016/J.Pharmthera.2005.11.004  0.427
2006 Linden AM, Aller MI, Leppä E, Vekovischeva O, Aitta-Aho T, Veale EL, Mathie A, Rosenberg P, Wisden W, Korpi ER. The in vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the alpha(2) adrenergic sedative dexmedetomidine, and cannabinoid agonists. The Journal of Pharmacology and Experimental Therapeutics. 317: 615-26. PMID 16397088 DOI: 10.1124/Jpet.105.098525  0.364
2006 Alexander SPH, Mathie A, Peters JA. Acid-sensing ion channels British Journal of Pharmacology. DOI: 10.1038/Sj.Bjp.0706605  0.344
2006 Alexander SPH, Mathie A, Peters JA. Sodium (voltage-gated) British Journal of Pharmacology. DOI: 10.1038/Sj.Bjp.0706599  0.306
2006 Alexander SPH, Mathie A, Peters JA. Cyclic nucleotide-gated channels British Journal of Pharmacology. DOI: 10.1038/Sj.Bjp.0706593  0.384
2006 Alexander SPH, Mathie A, Peters JA. ZAC (zinc-activated channel) British Journal of Pharmacology. DOI: 10.1038/Sj.Bjp.0706578  0.377
2005 Aller MI, Veale EL, Linden AM, Sandu C, Schwaninger M, Evans LJ, Korpi ER, Mathie A, Wisden W, Brickley SG. Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11455-67. PMID 16339039 DOI: 10.1523/Jneurosci.3153-05.2005  0.378
2005 Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL, Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine British Journal of Pharmacology. 144: 821-829. PMID 15685212 DOI: 10.1038/Sj.Bjp.0706068  0.415
2004 Gruss M, Mathie A, Lieb WR, Franks NP. The two-pore-domain K(+) channels TREK-1 and TASK-3 are differentially modulated by copper and zinc. Molecular Pharmacology. 66: 530-7. PMID 15322244 DOI: 10.1124/Mol.66.3  0.395
2004 Clarke CE, Veale EL, Green PJ, Meadows HJ, Mathie A. Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc Journal of Physiology. 560: 51-62. PMID 15284350 DOI: 10.1113/Jphysiol.2004.070292  0.345
2004 Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Molecular Pharmacology. 65: 443-52. PMID 14742687 DOI: 10.1124/Mol.65.2.443  0.377
2003 Mathie A, Kennard LE, Veale EL. Neuronal ion channells and their sensitivity to extremely low frequency weak electric field effects Radiation Protection Dosimetry. 106: 311-316. PMID 14690272 DOI: 10.1093/Oxfordjournals.Rpd.A006365  0.379
2003 Mathie A, Clarke CE, Ranatunga KM, Veale EL. What are the roles of the many different types of potassium channel expressed in cerebellar granule cells? Cerebellum. 2: 11-25. PMID 12882230 DOI: 10.1080/14734220310015593  0.424
2002 Mathie A, Clarke CE. Background potassium channels move into focus Journal of Physiology. 542: 334. PMID 12122133 DOI: 10.1113/Jphysiol.2002.020008  0.37
2002 Bushell T, Clarke C, Mathie A, Robertson B. Pharmacological characterization of a non-inactivating outward current observed in mouse cerebellar Purkinje neurones. British Journal of Pharmacology. 135: 705-12. PMID 11834618 DOI: 10.1038/Sj.Bjp.0704518  0.39
2000 Boyd DF, Millar JA, Watkins CS, Mathie A. The role of Ca2+ stores in the muscarinic inhibition of the K+ current IK(SO) in neonatal rat cerebellar granule cells. The Journal of Physiology. 529: 321-31. PMID 11101643 DOI: 10.1111/J.1469-7793.2000.00321.X  0.358
2000 Prothero LS, Mathie A, Richards CD. Purinergic and muscarinic receptor activation activates a common calcium entry pathway in rat neocortical neurons and glial cells Neuropharmacology. 39: 1768-1778. PMID 10884558 DOI: 10.1016/S0028-3908(00)00013-7  0.326
2000 Jones G, Boyd DF, Yeung SY, Mathie A. Inhibition of delayed rectifier K+ conductance in cultured rat cerebellar granule neurons by activation of calcium-permeable AMPA receptors European Journal of Neuroscience. 12: 935-944. PMID 10762323 DOI: 10.1046/J.1460-9568.2000.00983.X  0.416
2000 Millar JA, Barratt L, Southan AP, Page KM, Fyffe RE, Robertson B, Mathie A. A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons. Proceedings of the National Academy of Sciences of the United States of America. 97: 3614-8. PMID 10725353 DOI: 10.1073/Pnas.97.7.3614  0.442
1999 Yeung SY, Millar JA, Mathie A. Inhibition of neuronal K(v) potassium currents by the antidepressant drug, fluoxetine British Journal of Pharmacology. 128: 1609-1615. PMID 10602343 DOI: 10.1038/Sj.Bjp.0702955  0.417
1998 Prothero LS, Richards CD, Mathie A. Inhibition by inorganic ions of a sustained calcium signal evoked by activation of mGlu5 receptors in rat cortical neurons and glia British Journal of Pharmacology. 125: 1551-1561. PMID 9884084 DOI: 10.1038/Sj.Bjp.0702203  0.316
1998 Amos BJ, Mathie A, Richards CD. Activation of group I metabotropic glutamate receptors elicits pH changes in cultured rat cortical glia and neurons Neuroscience. 86: 1109-1120. PMID 9697118 DOI: 10.1016/S0306-4522(98)00072-4  0.325
1998 Clark S, Jordt SE, Jentsch TJ, Mathie A. Characterization of the hyperpolarization-activated chloride current in dissociated rat sympathetic neurons. The Journal of Physiology. 506: 665-78. PMID 9503329 DOI: 10.1111/J.1469-7793.1998.665Bv.X  0.636
1998 Mathie A, Wooltorton JR, Watkins CS. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. General Pharmacology. 30: 13-24. PMID 9457476 DOI: 10.1016/S0306-3623(97)00034-7  0.399
1996 Watkins CS, Mathie A. A non-inactivating K+ current sensitive to muscarinic receptor activation in rat cultured cerebellar granule neurons Journal of Physiology. 491: 401-412. PMID 8866863 DOI: 10.1113/Jphysiol.1996.Sp021224  0.358
1996 Watkins CS, Mathie A. Effects on K+ currents in rat cerebellar granule neurones of a membrane-permeable analogue of the calcium chelator BAPTA British Journal of Pharmacology. 118: 1772-1778. PMID 8842443 DOI: 10.1111/J.1476-5381.1996.Tb15603.X  0.362
1995 Hille B, Beech DJ, Bernheim L, Mathie A, Shapiro MS, Wollmuth LP. Multiple G-protein-coupled pathways inhibit N-type Ca channels of neurons. Life Sciences. 56: 989-92. PMID 10188803 DOI: 10.1016/0024-3205(95)00038-8  0.374
1995 Wooltorton JR, Mathie A. Potent block of potassium currents in rat isolated sympathetic neurones by the uncharged form of amitriptyline and related tricyclic compounds. British Journal of Pharmacology. 116: 2191-200. PMID 8564248 DOI: 10.1111/J.1476-5381.1995.Tb15053.X  0.342
1994 Watkins CS, Mathie A. Modulation of the gating of the transient outward potassium current of rat isolated cerebellar granule neurons by lanthanum PflüGers Archiv European Journal of Physiology. 428: 209-216. PMID 7816543 DOI: 10.1007/Bf00724499  0.358
1993 Wooltorton JR, Mathie A. Block of potassium currents in rat isolated sympathetic neurones by tricyclic antidepressants and structurally related compounds. British Journal of Pharmacology. 110: 1126-32. PMID 8298801 DOI: 10.1111/J.1476-5381.1993.Tb13931.X  0.325
1992 Yang J, Mathie A, Hille B. 5-HT3 receptor channels in dissociated rat superior cervical ganglion neurons. The Journal of Physiology. 448: 237-56. PMID 1375636 DOI: 10.1113/Jphysiol.1992.Sp019039  0.41
1992 Bernheim L, Mathie A, Hille B. Characterization of muscarinic receptor subtypes inhibiting Ca2+ current and M current in rat sympathetic neurons. Proceedings of the National Academy of Sciences of the United States of America. 89: 9544-8. PMID 1329101 DOI: 10.1073/Pnas.89.20.9544  0.38
1992 Mathie A, Bernheim L, Hille B. Inhibition of N- and L-type calcium channels by muscarinic receptor activation in rat sympathetic neurons. Neuron. 8: 907-14. PMID 1316767 DOI: 10.1016/0896-6273(92)90205-R  0.386
1991 Beech DJ, Bernheim L, Mathie A, Hille B. Intracellular Ca2+ buffers disrupt muscarinic suppression of Ca2+ current and M current in rat sympathetic neurons. Proceedings of the National Academy of Sciences of the United States of America. 88: 652-6. PMID 1846449 DOI: 10.1073/Pnas.88.2.652  0.326
1991 Mathie A, Cull-Candy SG, Colquhoun D. Conductance and kinetic properties of single nicotinic acetylcholine receptor channels in rat sympathetic neurones. The Journal of Physiology. 439: 717-50. PMID 1716680 DOI: 10.1113/Jphysiol.1991.Sp018690  0.424
1991 Wyllie DJ, Mathie A, Symonds CJ, Cull-Candy SG. Activation of glutamate receptors and glutamate uptake in identified macroglial cells in rat cerebellar cultures. The Journal of Physiology. 432: 235-58. PMID 1653320 DOI: 10.1113/Jphysiol.1991.Sp018383  0.333
1990 Colquhoun D, Cachelin AB, Marshall CG, Mathie A, Ogden DC. Function of nicotinic synapses. Progress in Brain Research. 84: 43-50. PMID 2267314 DOI: 10.1016/S0079-6123(08)60887-0  0.334
1990 Mathie A, Colquhoun D, Cull-Candy SG. Rectification of currents activated by nicotinic acetylcholine receptors in rat sympathetic ganglion neurones. The Journal of Physiology. 427: 625-55. PMID 1698982 DOI: 10.1113/Jphysiol.1990.Sp018191  0.37
1988 Cull-Candy SG, Mathie A, Powis DA. Acetylcholine receptor channels and their block by clonidine in cultured bovine chromaffin cells. The Journal of Physiology. 402: 255-78. PMID 2466982 DOI: 10.1113/Jphysiol.1988.Sp017203  0.387
1987 Mathie A, Cull-Candy SG, Colquhoun D. Single-channel and whole-cell currents evoked by acetylcholine in dissociated sympathetic neurons of the rat. Proceedings of the Royal Society of London. Series B, Biological Sciences. 232: 239-48. PMID 2892208 DOI: 10.1098/Rspb.1987.0072  0.439
1987 Colquhoun D, Ogden DC, Mathie A. Nicotinic acetylcholine receptors of nerve and muscle: Functional aspects Trends in Pharmacological Sciences. 8: 465-472. DOI: 10.1016/0165-6147(87)90040-X  0.306
1986 Blakeley AG, Mathie A, Petersen SA. Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens. British Journal of Pharmacology. 88: 807-14. PMID 3742159 DOI: 10.1111/J.1476-5381.1986.Tb16253.X  0.626
1986 Cull-Candy SG, Mathie A. Ion channels activated by acetylcholine and gamma-aminobutyric acid in freshly dissociated sympathetic neurones of the rat. Neuroscience Letters. 66: 275-80. PMID 2425288 DOI: 10.1016/0304-3940(86)90031-5  0.404
1984 Blakeley AG, Cunnane TC, Maskell T, Mathie A, Petersen SA. Alpha-adrenoceptors and facilitation at a sympathetic neuroeffector junction. Journal of Autonomic Pharmacology. 4: 53-8. PMID 6325465 DOI: 10.1111/J.1474-8673.1984.Tb00433.X  0.616
1984 Blakeley AG, Mathie A, Petersen SA. Facilitation at single release sites of a sympathetic neuroeffector junction in the mouse. The Journal of Physiology. 349: 57-71. PMID 6145793 DOI: 10.1113/Jphysiol.1984.Sp015142  0.625
Show low-probability matches.